Explore the details of Edema in this guide—from its causes and symptoms to possible complications and treatment options.

Perilipin 5 as mediator of high-fat diet-induced hepatocellular carcinoma immune escape by stabilization of PD-L1 expression. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

Travere Therapeutics, Inc., today announced that the Company will present seven abstracts at the upcoming European Renal Association (ERA) Congress in Vienna, Austria, June 4-7. Presentations will ...

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response ...

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response ...

The aging process can affect your feet and ankles, causing changes in the skin, bone, joints, and circulation, including ...

A 46-year-old woman with type 1 myotonic dystrophy (DM1) presented to the emergency department with dyspnea and palpitations.

Blastic plasmacytoid dendric cell neoplasm (BPDCN) is a rare, aggressive blood cancer that often involves the bone marrow, skin and, sometimes, lymph ...

Recognize 5 crucial warning signs that indicate heart weakness. Early detection of these symptoms can help prevent serious ...

Common side effects of Emrelis include peripheral neuropathy, fatigue, decreased appetite, and peripheral edema, with some severe laboratory abnormalities observed. The U.S. FDA has approved treatment ...

and peripheral edema. The most common grade 3 or 4 laboratory abnormalities (≥2%) were decreases in lymphocytes, phosphorus, sodium, hemoglobin, and calcium, and increases in glucose ...

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.